Moleculin Biotech (MBRX) just unveiled an update.
Moleculin Biotech, Inc. has released a corporate presentation on its website, sharing insights into the company’s direction and performance. The presentation, while informative, is not considered an official filing under the Securities Exchange Act of 1934 or the Securities Act of 1933 and will not be included in any formal filings unless explicitly stated. This development could be of interest to investors tracking Moleculin Biotech’s market activities.
For an in-depth examination of MBRX stock, go to TipRanks’ Stock Analysis page.
